India and the European Union have concluded a landmark Free Trade Agreement (FTA), with analysts describing the deal as far more than a tariff-reduction exercise — it is, according to a detailed assessment in Modern Diplomacy, a framework for building strategic economic trust between two major powers navigating a fractured global order. The agreement arrives as both partners seek to diversify away from risky dependencies, particularly in the wake of renewed protectionist pressures following Donald Trump's return to the US presidency.

More Than Market Access

The Modern Diplomacy article argues that the most consequential trade agreements today are no longer defined by customs schedules alone. 'As countries seek to diversify away from risky dependencies without retreating from globalisation, trade agreements are increasingly becoming instruments of strategic trust as much as market access,' it noted. The EU-India FTA, spanning twenty chapters and containing as many as 125 cooperation provisions, reflects precisely that shift — embedding regulatory dialogue, institutional coordination, and transparency mechanisms across sectors.

Pharmaceuticals: Tariffs Are Only the Beginning

India supplies affordable medicines to more than 200 countries and remains the world's largest source of generic pharmaceuticals, yet the EU has absorbed only a modest share of that capacity. The FTA makes significant tariff commitments in pharmaceuticals and medical devices. However, as the article cautions, tariff elimination alone does not produce market access — regulators, not customs schedules, ultimately determine outcomes. Indian producers have long held the grievance of having to secure separate regulatory approvals in each EU member state. Through structured regulatory cooperation embedded in the agreement, there is potential for greater harmonisation of approval processes across the bloc over time, reinforcing the integrity of the single market while easing Indian exporters' path.

CBAM: From Confrontation to Engagement

The EU's Carbon Border Adjustment Mechanism (CBAM) became fully operational this year, and the FTA does not exempt India from it. This is consequential given the exposure of India's steel and aluminium exporters. Notably, India moved from a posture of threatening confrontation over the CBAM to negotiating the terms of engagement within it — a strategic recalibration the article describes as significant. Whether that engagement converts into tangible relief for Indian industry, however, 'remains open, a question the FTA's text alone cannot answer,' it cautioned. More broadly, the CBAM framework illustrates how modern trade agreements increasingly serve as vehicles for domestic reform on both sides: India may use the agreement to accelerate industrial decarbonisation, while the EU will need to simplify aspects of its own CBAM architecture for cooperation to function effectively.

What India Stands to Gain

For India, the gains extend well beyond export volumes. As the country builds out manufacturing capacity, innovation infrastructure, and its credentials as a trusted supply-chain partner, Europe offers capital, technology, and research collaboration that pure trade flows cannot capture. The agreement is to be supplemented in the coming months by a parallel investment protection agreement and Indian participation in the EU's Horizon Europe flagship research programmes. 'Cooperation is the throughline across sectors from medical technology to clean energy to digital services; competitiveness increasingly depends on the ability of two systems to work together, not on one converging toward the other,' the article stated. If utilised strategically, the deal could propel India's internal competitiveness and regulatory reform agenda.

EU's Strategic Recalibration on India

For the European Union, the agreement signals a fundamental reappraisal of how it views India — no longer simply an emerging market to be courted, or a counterweight to China, but a partner whose cooperation on carbon standards, supply-chain resilience, and regulatory frameworks Europe now actively needs. The article describes the deal as 'a belated recognition by the EU that India is its full equal.' This comes amid a broader global reconfiguration, with major economies reassessing supply-chain dependencies and seeking reliable long-term partners beyond the traditional US-China axis.